Citations

Clear

3138 citation(s) found for "Smith, AM".

Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation
Tranguch, Susanne , Cheung‐Flynn, Joyce , Daikoku, Takiko , Prapapanich, Viravan, Cox, Marc B. , Xie, Huirong , Smith, David F. , Wang, Haibin , Das, Sanjoy K. , Dey, Sudhansu K.

Mayo Clinic

Proceedings of the National Academy of Sciences | September 21, 2005 | Volume: 102 | Issue: 40 | Pages: 14326-14331

10.1073/pnas.0505775102 | PMID 16176985 Get It

Embryo implantation in the uterus is a critical step in mammalian reproduction, requiring preparation of the uterus receptive to blastocyst implantation. Uterine receptivity, also known as the window of implantation, lasts for a limited period, and it is during this period blastocysts normally implant. Ovarian steroid hormones estrogen and progesterone (P 4 ) are the primary regulators of this process. The immunophilin FKBP52 serves as a cochaperone for steroid hormone nuclear receptors to govern appropriate hormone action in target tissues. Here we show a critical role for FKBP52 in mouse implantation. This immunophilin has unique spatiotemporal expression in the uterus during implantation, and females missing the Fkbp52 gene have complete implantation failure due to lack of attainment of uterine receptivity. The overlapping uterine expression of FKBP52 with nuclear progesterone receptor (PR) in wild-type mice together with reduced P 4 binding to PR, attenuated PR transcriptional activity and down-regulation of several P 4 -regulated genes in uteri of Fkbp52 -/- mice, establishes this cochaperone as a critical regulator of uterine P 4 function. Interestingly, ovulation, another P 4 -mediated event, remains normal. Collectively, the present investigation provides evidence for an in vivo role for this cochaperone in regulating tissue-specific hormone action and its critical role in uterine receptivity for implantation.
Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes
Pett, Mark R., Alazawi, William , Roberts, Ian , Dowen, Sally E., Smith, David I., Stanley, Margaret , Coleman, Nicholas , Smith, David I.

Mayo Clinic

Cancer Research | September 20, 2005 | Volume: 64 | Issue: 4 | Pages: 1359-1368

10.1158/0008-5472.can-03-3214 | PMID 14973079 Get It

Abstract Whereas two key steps in cervical carcinogenesis are integration of high-risk human papillomavirus (HR-HPV) and acquisition of an unstable host genome, the temporal association between these events is poorly understood. Chromosomal instability is induced when HR-HPV E7 oncoprotein is overexpressed from heterologous promoters in vitro. However, it is not known whether such events occur at the “physiologically” elevated levels of E7 produced by deregulation of the homologous HR-HPV promoter after integration. Indeed, an alternative possibility is that integration in vivo is favored in an already unstable host genome. We have addressed these issues using the unique human papillomavirus (HPV) 16-containing cervical keratinocyte cell line W12, which was derived from a low-grade squamous intraepithelial lesion and thus acquired HPV16 by “natural” infection. Whereas W12 at low passage contains HPV16 episomes only, long-term culture results in the emergence of cells containing integrated HPV16 only. We show that integration of HPV16 in W12 is associated with 3′ deletion of the E2 transcriptional repressor, resulting in deregulation of the homologous promoter of the integrant and an increase in E7 protein levels. We further demonstrate that high-level chromosomal instability develops in W12 only after integration and that the forms of instability observed correlate with the physical state of HPV16 DNA and the level of E7 protein. Whereas intermediate E7 levels are associated with numerical chromosomal abnormalities, maximal levels are associated with both numerical and structural aberrations. HR-HPV integration is likely to be a critical event in cervical carcinogenesis, preceding the development of chromosomal abnormalities that drive malignant progression.
Fruits and Vegetables and Ovarian Cancer Risk in a Pooled Analysis of 12 Cohort Studies
Koushik, Anita , Anderson, Kristin E. , Arslan, Alan A. , Brandt, Piet A. van den , Buring, Julie E. , Cerhan, James R. , Colditz, Graham A. , Fraser, Gary E. , Freudenheim, Jo L. , Goldbohm, R. Alexandra, Hankinson, Susan E. , Koenig, Karen L. , Larsson, Susanna C. , Leitzmann, Michael F. , McCullough, Marjorie L. , Miller, Anthony B. , Patel, Alpa V. , Rohan, Thomas E. , Schatzkin, Arthur, Smit, Ellen, Zhang, Shumin M., Smith‐Warner, Stephanie A. , Hunter, David J. , Spiegelman, Donna , Beeson, W. Lawrence , Genkinger, Jeanine M. , Hankinson, Susan E. , Willett, Walter C. , Wolk, Alicja , Cerhan, James R , Koushik, Anita , Arslan, Alan A , Colditz, Graham A , Larsson, Susanna C , McCullough, Marjorie L

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | September 20, 2005 | Volume: 14 | Issue: 9 | Pages: 2160-2167

10.1158/1055-9965.epi-05-0218 | PMID 16172226 Get It

AbstractBecause fruits and vegetables are rich in bioactive compounds with potential cancer-preventive actions, increased consumption may reduce the risk of ovarian cancer. Evidence on the association between fruit and vegetable intake and ovarian cancer risk has not been consistent. We analyzed and pooled the primary data from 12 prospective studies in North America and Europe. Fruit and vegetable intake was measured at baseline in each study using a validated food-frequency questionnaire. To summarize the association between fruit and vegetable intake and ovarian cancer, study-specific relative risks (RR) were estimated using the Cox proportional hazards model, and then combined using a random-effects model. Among 560,441 women, 2,130 cases of invasive epithelial ovarian cancer occurred during a maximum follow-up of 7 to 22 years across studies. Total fruit intake was not associated with ovarian cancer risk—the pooled multivariate RR for the highest versus the lowest quartile of intake was 1.06 [95% confidence interval (95% CI), 0.92-1.21; P value, test for trend = 0.73; P value, test for between-studies heterogeneity = 0.74]. Similarly, results for total vegetable intake indicated no significant association (pooled multivariate RR, 0.90; 95% CI, 0.78-1.04, for the highest versus the lowest quartile; P value, test for trend = 0.06; P value, test for between-studies heterogeneity = 0.31). Intakes of botanically defined fruit and vegetable groups and individual fruits and vegetables were also not associated with ovarian cancer risk. Associations for total fruits and vegetables were similar for different histologic types. These results suggest that fruit and vegetable consumption in adulthood has no important association with the risk of ovarian cancer.
Completion pancreatectomy following pancreaticoduodenectomy: Clinical experience
Smith, C. Daniel , Sarr, Michael G., vanHeerden, Jon A.

Mayo Clinic

World Journal of Surgery | September 13, 2005 | Volume: 16 | Issue: 3 | Pages: 521-524

10.1007/bf02104459 | PMID 1350387 Get It

AbstractWhile pancreaticoduodenectomy is today performed with an operative mortality of <5%, the incidence of significant operative morbidity remains at least 25%. Albeit rarely, completion pancreatectomy during the early postoperative period may be required to manage uncontrolled pancreatic anastomotic leaks. From 1964 to 1988, pancreaticoduodenectomy was performed on 479 patients at our institution, 178 (37%) of whom required re‐operation in the early postoperative period. Of these, 11 (6%) patients underwent completion pancreatectomy at a mean interval of 18 days following Whipple resection. The indications prompting re‐operation included a suspected pancreatic leak (n=8), intra‐abdominal hemorrhage (n=2), and pancreaticocutaneous fistula (n=1). Operative findings necessitating completion pancreatectomy included pancreatic anastomotic dehiscence with severe surrounding inflammation/necrosis prohibiting reanastomosis or repair (n=10) and necrotizing pancreatitis with uncontrolled hemorrhage (1). Seven (64%) of these 11 patients died postoperatively of sepsis and multiple organ failure. The mean hospital stay in the 4 surviving patients was 46 days (range, 26 to 53 days). These 4 patients survived for a mean period of 24 months following hospital dismissal.
Pregnancy-Associated Plasma Protein-A Is Involved in Matrix Mineralization of Human Adult Mesenchymal Stem Cells and Angiogenesis in the Chick Chorioallontoic Membrane
Jadlowiec, Julie, Dongell, Diana, Smith, Jason D. , Conover, Cheryl A. , Campbell, Phil G.

Mayo Clinic

Endocrinology | May 26, 2005 | Volume: 146 | Issue: 9 | Pages: 3765-3772

10.1210/en.2004-1351 | PMID 15919757 Get It

Selective antibody immune deficiency in a patient with Smith–Lemli–Opitz syndrome
Babovic‐Vuksanovic, Dusica , Jacobson, Robert M. , Lindor, Noralane M. , Weiler, Catherine R., Jacobson, Robert M

Mayo Clinic

Journal of Inherited Metabolic Disease | May 4, 2005 | Volume: 28 | Issue: 2 | Pages: 181-186

10.1007/s10545-005-5515-3 | PMID 15877207 Get It

SummarySmith–Lemli–Opitz syndrome is a rare autosomal recessive disorder characterized by multiple congenital anomalies and various degrees of cognitive deficits. This condition results from a deficiency of 7‐dehydrocholesterol reductase, a critical step in cholesterol biosynthesis. Children with Smith–Lemli–Opitz syndrome have frequent infections, particularly of the respiratory tract. Immunodeficiency, however, is not recognized as a part of this metabolic condition. Frequent infections are usually attributed to a decreased patient mobility and reduced respiratory effort secondary to muscular hypotonia and mental retardation, which are often present in affected individuals. We describe a patient with Smith–Lemli–Opitz syndrome and recurrent respiratory infections who was found to have a selective antibody deficiency. The immunological diagnosis was based on an absent immune response to Pneumovax. She also had no immunological response to hepatitis B vaccine and was unable to break down red cells with isoagglutinin B. Therapy with intravenous IgG (IVIG) was initiated. Infections were less severe, although they still occurred in a high frequency after initiation of the IVIG therapy. This finding prompts the need for a higher index of suspicion for an underlying immune deficiency in patients with Smith–Lemli–Opitz syndrome who present with recurrent and chronic infections. Early recognition and appropriate therapeutic interventions may decrease the severity of infections, prevent potentially fatal infections, and eventually improve the quality of life in these patients.
Physiological Role for the Cochaperone FKBP52 in Androgen Receptor Signaling
Cheung‐Flynn, Joyce , Prapapanich, Viravan, Cox, Marc B. , Suárez‐Quian, Carlos A. , Riggs, Daniel L. , Smith, David F.

Mayo Clinic

Molecular Endocrinology | April 15, 2005 | Volume: 19 | Issue: 6 | Pages: 1654-1666

10.1210/me.2005-0071 | PMID 15831525 Get It

AbstractMolecular chaperones mediate multiple aspects of steroid receptor function, but the physiological importance of most receptor-associated cochaperones has not been determined. To help fill this gap, we targeted for disruption the mouse gene for the 52-kDa FK506 binding protein, FKBP52, a 90-kDa heat shock protein (Hsp90)-binding immunophilin found in steroid receptor complexes. A mouse line lacking FKBP52 (52KO) was generated and characterized. Male 52KO mice have several defects in reproductive tissues consistent with androgen insensitivity; among these defects are ambiguous external genitalia and dysgenic prostate. FKBP52 and androgen receptor (AR) are coexpressed in prostate epithelial cells of wild-type mice. However, FKBP52 and AR are similarly coexpressed in testis even though testis morphology and spermatogenesis in 52KO males are usually normal. Molecular studies confirm that FKBP52 is a component of AR complexes, and cellular studies in yeast and human cell models demonstrate that FKBP52 can enhance AR-meditated transactivation. AR enhancement requires FKBP52 peptidylprolyl isomerase activity as well as Hsp90-binding ability, and enhancement probably relates to an affect of FKBP52 on AR-folding pathways. In the presence of FKBP52, but not other cochaperones, the function of a minimally active AR point mutant can be dramatically restored. We conclude that FKBP52 is an AR folding factor that has critically important physiological roles in some male reproductive tissues.
Sequencing and Resolution of Amplified Herpes Simplex Virus DNA with Intermediate Melting Curves as Genotype 1 or 2 by LightCycler PCR Assay
Issa, Nicolas C. , Espy, Mark J., Uhl, James R., Smith, Thomas F.

Mayo Clinic

Journal of Clinical Microbiology | April 6, 2005 | Volume: 43 | Issue: 4 | Pages: 1843-1845

10.1128/jcm.43.4.1843-1845.2005 | PMID 15815006 Get It

ABSTRACT DNA from 101 specimens containing herpes simplex virus (HSV) produced atypical intermediate melting curves compared with those expected for HSV type 1 or HSV type 2 subsequent to real-time PCR. Nucleic acid sequence analysis of amplified target DNA revealed 1- or 3-bp polymorphisms in the probe region which allowed designation of these viruses as HSV genotype 1 or HSV genotype 2. These two subpopulations of HSV were also identified as HSV genotype 1 or HSV genotype 2 using another commercially available PCR method. Amplified HSV target DNA producing intermediate melting curves could be designated as HSV genotype 1 or HSV genotype 2 without performing sequencing or another PCR method with 96/101 (95%) specimens by adding known intermediate HSV DNA characteristic for the two subpopulations as controls.
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Loegering, David A., Powell, Heather L., Flatten, Karen S., Arlander, Sonnet J.H., Dai, Nga T., Heldebrant, Michael P., Vroman, Benjamin T., Karp, Judith E. , Eyck, Cynthia J. Ten, Erlichman, Charles , Karnitz, Larry M., Mesa, Ruben A. , Smith, B. Douglas , Eyck, Cynthia Ten, Kaufmann, Scott H.

Mayo Clinic

Blood | March 23, 2005 | Volume: 106 | Issue: 1 | Pages: 318-327

10.1182/blood-2004-09-3523 | PMID 15784732 Get It

Previous studies demonstrated that ataxia telangiectasia mutated– and Rad3-related (ATR) kinase and its downstream target checkpoint kinase 1 (Chk1) facilitate survival of cells treated with nucleoside analogs and other replication inhibitors. Recent results also demonstrated that Chk1 is depleted when cells are treated with heat shock protein 90 (Hsp90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG). The present study examined the effects of 17-AAG and its major metabolite, 17-aminogeldanamycin (17-AG), on Chk1 levels and cellular responses to cytarabine in human acute myelogenous leukemia (AML) cell lines and clinical isolates. Cytarabine, at concentrations as low as 30 nM, caused activating phosphorylation of Chk1, loss of the phosphatase Cdc25A, and S-phase slowing. Conversely, treatment with 100 to 300 nM 17-AAG for 24 hours caused Chk1 depletion that was accompanied by diminished cytarabine-induced S-phase accumulation, decreased Cdc25A degradation, and enhanced cytotoxicity as measured by inhibition of colony formation and induction of apoptosis. Additional studies demonstrated that small inhibitory RNA (siRNA) depletion of Chk1 also sensitized cells to cytarabine, whereas disruption of the phosphatidylinositol 3-kinase (PI3k) signaling pathway, which is also blocked by Hsp90 inhibition, did not. Collectively, these results suggest that treatment with 17-AAG might represent a means of reversing checkpoint-mediated cytarabine resistance in AML.
Comparison of Specimen Processing and Nucleic Acid Extraction by the Swab Extraction Tube System versus the MagNA Pure LC System for Laboratory Diagnosis of Herpes Simplex Virus Infections by LightCycler PCR
Issa, Nicolas C. , Espy, Mark J., Uhl, J. R., Harmsen, William S. , Mandrekar, Jayawant N. , Gullerud, R. E., Davis, Mike , Smith, Thomas F.

Mayo Clinic

Journal of Clinical Microbiology | March 4, 2005 | Volume: 43 | Issue: 3 | Pages: 1059-1063

10.1128/jcm.43.3.1059-1063.2005 | PMID 15750060 Get It

ABSTRACT A total of 563 specimens (234 dermal and 329 genital swabs) from patients suspected of having herpes simplex virus (HSV) infections were processed using two different extraction methods (the MagNA Pure LC system and the swab extraction tube system [SETS]); HSV DNA was amplified by LightCycler PCR. HSV DNA was detected in 157 of 563 specimens (27.9%) processed by the MagNA Pure LC system and in 179 of 563 specimens (31.8%) processed by SETS ( P < 0.0001). There was no specimen processed by the MagNA Pure LC extraction method that was positive only for HSV DNA. Of 157 specimens positive by both methods, HSV DNA copy levels were higher (using cycle crossover points [cycle threshold { C T }]) with SETS (mean C T , 25.9 cycles) than with the MagNA Pure LC system (mean C T , 32.0 cycles) ( P < 0.0001). The time to process 32 samples was longer with the MagNA Pure LC extraction system (90 min) than with SETS (35 min). HSV DNA extraction using SETS is faster, less expensive, and more sensitive than the MagNA Pure LC system and could replace the latter for the laboratory diagnosis of HSV infections using LightCycler PCR.